Related Experiment Video
Updated: Jan 4, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
593
Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate Cancer
1The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|November 13, 2019
Abstract
None:
Evidence is accumulating for seven and less fractions in localised prostate cancer, including one large randomised trial. However, there is much more evidence yet to come and changing practice in advance of this may be premature. We review the reasons to persist with moderate hypofractionation for prostate cancer radiotherapy, until the results of further phase III studies are known.
